The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis

Colorectal cancer (CRC) is a major cause of mortality in western society with a 5-year survival of approximately 50%. Metastasis to the liver and lungs is the principal cause of death and occurs in up to 25% of patients at presentation. Despite advances in available techniques for treating metastase...

Full description

Bibliographic Details
Main Authors: John Conti, Gareth Thomas
Format: Article
Language:English
Published: MDPI AG 2011-04-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/3/2/2160/
id doaj-94f7a04e5c8844f89459bf011740806e
record_format Article
spelling doaj-94f7a04e5c8844f89459bf011740806e2020-11-24T21:08:07ZengMDPI AGCancers2072-66942011-04-01322160216810.3390/cancers3022160The Role of Tumour Stroma in Colorectal Cancer Invasion and MetastasisJohn ContiGareth ThomasColorectal cancer (CRC) is a major cause of mortality in western society with a 5-year survival of approximately 50%. Metastasis to the liver and lungs is the principal cause of death and occurs in up to 25% of patients at presentation. Despite advances in available techniques for treating metastases, the majority of patients remain incurable and existing adjuvant therapies such as chemotherapy are only of limited effectiveness. Understanding the molecular mechanisms underlying the metastatic process may allow us to identify those at greatest risk of recurrence and discover new tumour targets to prevent disease progression. It is now apparent that tumour stroma plays an important role in promoting tumour progression. A pronounced desmoplastic reaction was associated with a reduced immune response and has been shown to be an independent poor prognostic indicator in CRC and cancer recurrence. Determining the cause(s) and effect(s) of this stromal response will further our understanding of tumour cell/stromal interactions, and will help us identify prognostic indicators for patients with CRC. This will not only allow us to target our existing treatments more effectively, we also aim to identify novel and more specific therapeutic targets for the treatment of CRC which will add to our current therapeutic options.http://www.mdpi.com/2072-6694/3/2/2160/colorectal cancerstromamyofibroblaststumour microenvironment
collection DOAJ
language English
format Article
sources DOAJ
author John Conti
Gareth Thomas
spellingShingle John Conti
Gareth Thomas
The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis
Cancers
colorectal cancer
stroma
myofibroblasts
tumour microenvironment
author_facet John Conti
Gareth Thomas
author_sort John Conti
title The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis
title_short The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis
title_full The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis
title_fullStr The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis
title_full_unstemmed The Role of Tumour Stroma in Colorectal Cancer Invasion and Metastasis
title_sort role of tumour stroma in colorectal cancer invasion and metastasis
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2011-04-01
description Colorectal cancer (CRC) is a major cause of mortality in western society with a 5-year survival of approximately 50%. Metastasis to the liver and lungs is the principal cause of death and occurs in up to 25% of patients at presentation. Despite advances in available techniques for treating metastases, the majority of patients remain incurable and existing adjuvant therapies such as chemotherapy are only of limited effectiveness. Understanding the molecular mechanisms underlying the metastatic process may allow us to identify those at greatest risk of recurrence and discover new tumour targets to prevent disease progression. It is now apparent that tumour stroma plays an important role in promoting tumour progression. A pronounced desmoplastic reaction was associated with a reduced immune response and has been shown to be an independent poor prognostic indicator in CRC and cancer recurrence. Determining the cause(s) and effect(s) of this stromal response will further our understanding of tumour cell/stromal interactions, and will help us identify prognostic indicators for patients with CRC. This will not only allow us to target our existing treatments more effectively, we also aim to identify novel and more specific therapeutic targets for the treatment of CRC which will add to our current therapeutic options.
topic colorectal cancer
stroma
myofibroblasts
tumour microenvironment
url http://www.mdpi.com/2072-6694/3/2/2160/
work_keys_str_mv AT johnconti theroleoftumourstromaincolorectalcancerinvasionandmetastasis
AT gareththomas theroleoftumourstromaincolorectalcancerinvasionandmetastasis
AT johnconti roleoftumourstromaincolorectalcancerinvasionandmetastasis
AT gareththomas roleoftumourstromaincolorectalcancerinvasionandmetastasis
_version_ 1716760786989219840